What metabolic health actually means
Metabolic health describes the state in which the body's energy regulation systems are functioning optimally: blood sugar rises appropriately after meals and returns to baseline efficiently; insulin is produced in appropriate amounts and cells respond to it effectively; blood lipids reflect a non-atherogenic pattern; blood pressure is maintained without pharmacological support; body fat distribution is predominantly subcutaneous rather than visceral; and inflammatory markers are within ranges that indicate minimal chronic disease burden.
By this definition, using the commonly referenced criteria of five metabolic health markers, research finds that only 12–15% of adults in high-income countries are metabolically healthy. The remainder have sub-optimal function in one or more metabolic systems, even if they fall below the diagnostic thresholds for any specific metabolic disease. This is the space between 'not sick' and 'genuinely well', and it is where metabolic disease develops over the decade or more preceding diagnosis.
The metabolic health cascade
Metabolic decline follows a predictable sequence, not a simultaneous deterioration across all markers, but a cascade in which early changes in one system create conditions for deterioration in others.
It typically begins with subclinical insulin resistance, cells becoming less responsive to insulin before blood sugar rises. Fasting insulin elevates; blood sugar remains normal. This is the compensated phase, lasting years to decades, during which the pancreas maintains normal glucose by producing increasing amounts of insulin.
Elevated insulin then drives lipid dysregulation, elevated triglycerides, reduced HDL, and the production of small dense LDL particles that are more atherogenic than standard LDL measurement captures. This dyslipidaemia pattern appears years before blood sugar rises.
Simultaneously, elevated insulin promotes sodium retention in the kidneys and sympathetic activation, producing the blood pressure elevation that characterises metabolic syndrome. Blood pressure rises gradually, often attributed to stress or ageing rather than recognised as a metabolic consequence.
The accumulation of visceral fat, fat in and around abdominal organs, produces an adipokine environment that amplifies all the above: elevated leptin, reduced adiponectin, elevated TNF-alpha and IL-6, and further insulin resistance. The self-amplifying nature of visceral fat accumulation is why central obesity is the most predictive single marker of metabolic disease risk.
Eventually, pancreatic beta cell exhaustion produces the blood sugar elevation that crosses the diagnostic threshold, and diabetes is diagnosed. At this point, metabolic dysfunction has typically been established for 10–15 years.
Assessing metabolic health comprehensively
A comprehensive metabolic health assessment goes beyond the standard fasting glucose and total cholesterol. The minimum meaningful metabolic panel includes: fasting insulin and HOMA-IR (insulin resistance before blood sugar rises); HbA1c; full lipid panel including triglycerides, HDL, LDL, and non-HDL cholesterol; liver enzymes (ALT, AST, GGT) as markers of hepatic metabolic health; CRP as an inflammatory metabolic marker; blood pressure across multiple readings; and waist circumference as the most accessible visceral fat indicator.
These markers are interpreted together, not in isolation. A normal HbA1c with elevated fasting insulin and high triglycerides tells a different clinical story than normal HbA1c with normal insulin and normal lipids. The pattern matters as much as individual values.
Restoring metabolic health, the CLCC approach
Metabolic restoration in CLCC care is built around dietary structure as the primary intervention, because dietary patterns are the primary determinant of insulin demand, hepatic lipid accumulation, and visceral fat deposition. A low-insulin dietary protocol, reducing refined carbohydrates and fructose, prioritising protein and fibre, and structuring meal timing to allow adequate inter-meal insulin recovery, produces simultaneous improvement across all five metabolic health markers: blood sugar, insulin, lipids, blood pressure, and body composition.
Gut restoration addresses the microbiome-metabolic connection, SCFA production for insulin sensitivity, LPS reduction for inflammatory metabolic impairment. Resistance exercise adds direct insulin sensitisation through GLUT4 upregulation. Stress load reduction addresses cortisol-driven insulin resistance and hepatic glucose production. Sleep correction removes the insulin resistance produced by sleep deprivation. Each intervention contributes independently, and their combined effect is greater than any single intervention alone.